Refractory Endometrial Mixed Cell Adenocarcinoma
1 clinical trials · Condition
◉ Watch Refractory Endometrial Mixed Cell Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| Onapristone and Anastrozole for the Treatment of Refractory Hormone Receptor Positive Endometrial Cancer (NCT04719273) | Thomas Jefferson University | 2021-01-28 |
Track Refractory Endometrial Mixed Cell Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.